ARAV
Congressional Trades
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Bob GibbsHouse · R · OH |
ARAVARAV · Stock |
Sale $158.65 |
Jan 13, 2019 | Dec 28, 2018 | Filing ↗ |
Whale Activity
No 13F positions in ARAV among the institutional filers we track.
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Ho Peter Tai-ChingDirector | Grant / award Amended | +54.4K | $0.92 | $50K | Oct 24, 2022 | Form 4 ↗ |
| Zhang EricDirector | Grant / award Amended | +543.5K | $0.92 | $500K | Oct 24, 2022 | Form 4 ↗ |
| HOWARD RUDYChief Financial Officer | Grant / award | +10.9K | $0.92 | $10K | Oct 24, 2022 | Form 4 ↗ |
| Giaccia AmatoDirector | Grant / award | +271.8K | $0.92 | $250K | Oct 24, 2022 | Form 4 ↗ |
| Zhang EricDirector | Grant / award | +543.5K | $0.92 | $500K | Oct 24, 2022 | Form 4 ↗ |
| McIntyre Gail FrancesCEO and President · Director | Grant / award | +54.4K | $0.92 | $50K | Oct 24, 2022 | Form 4 ↗ |
| Ho Peter Tai-ChingDirector | Grant / award | +54.4K | $0.92 | $50K | Oct 24, 2022 | Form 4 ↗ |
| Eshelman Ventures, LLCDirector · 10% owner | Grant / award | +16.3M | $0.92 | $15.0M | Oct 24, 2022 | Form 4 ↗ |
| ESHELMAN FREDRIC NExecutive Chairman of Board · Director · 10% owner | Option exercise | +4.5M | $0.00 | $0 | Apr 1, 2022 | Form 4 ↗ |
| Eshelman Ventures, LLCDirector · 10% owner | Grant / award | +860.2K | $2.33 | $2.0M | Mar 29, 2022 | Form 4 ↗ |
| Giaccia AmatoDirector | Gift | −48.4K | $0.00 | $0 | Dec 3, 2021 | Form 4 ↗ |
| Giaccia AmatoDirector | Sale | −39 | $3.22 | $126 | Nov 30, 2021 | Form 4 ↗ |
| Giaccia AmatoDirector | Sale | −2,954 | $3.22 | $10K | Nov 30, 2021 | Form 4 ↗ |
| Giaccia AmatoDirector | Sale | −252 | $3.22 | $811 | Nov 30, 2021 | Form 4 ↗ |
| Giaccia AmatoDirector | Option exercise | +500 | $0.24 | $120 | Nov 30, 2021 | Form 4 ↗ |
| Giaccia AmatoDirector | Option exercise | +38.8K | $0.24 | $9K | Nov 30, 2021 | Form 4 ↗ |
| Giaccia AmatoDirector | Option exercise | +12.3K | $0.06 | $741 | Nov 30, 2021 | Form 4 ↗ |
| McIntyre Gail FrancesCEO and President · Director | Purchase | +1,000 | $5.35 | $5K | Jun 29, 2021 | Form 4 ↗ |
| Shah VinayChief Financial Officer | Purchase | +1,000 | $5.31 | $5K | Jun 29, 2021 | Form 4 ↗ |
| Giaccia AmatoDirector | Gift | −12.1K | $0.00 | $0 | Mar 19, 2021 | Form 4 ↗ |
Fund Holders
Funds report their holdings by CUSIP, and ARAV could not be matched to one, so no fund holdings are shown.
Activist & Passive Stakes
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
No lobbying filings found naming ARAV as the client.
Government Contracts
No federal contract awards found for ARAV.
U.S. Patents
No USPTO patent applications found for ARAV.
Annual Financials
No annual XBRL figures on record for ARAV. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
- 1-for-6Reverse splitOct 16, 2018
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
No 8-K filings on record.
About ARAV
No company profile on record.